CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Axsome's NDA for AXS-12 in Narcolepsy Gets FDA Acceptance

NDA FilingAXS-12Positive
AI Analysis

Summary

Axsome Therapeutics' New Drug Application for AXS-12 in narcolepsy has been accepted by the FDA for review. The acceptance represents progress toward potential regulatory approval of the candidate drug.

Outcome Details

NDA accepted by FDA

Importance:7/10
Sentiment:
0.70
FDANDAnarcolepsyregulatory
Related Companies

Read the original article

Published by yahoo_finance on July 16, 2026 3:58 PM

Read Original